BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30526687)

  • 1. Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.
    Christodoulou I; Goulielmaki M; Devetzi M; Panagiotidis M; Koliakos G; Zoumpourlis V
    Stem Cell Res Ther; 2018 Dec; 9(1):336. PubMed ID: 30526687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.
    Zhang YN; Lie PC; Wei X
    Cytotherapy; 2009; 11(5):548-58. PubMed ID: 19657806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents.
    Schneider RK; Püllen A; Kramann R; Bornemann J; Knüchel R; Neuss S; Perez-Bouza A
    Differentiation; 2010 Mar; 79(3):182-93. PubMed ID: 20153102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.
    Schneider RK; Puellen A; Kramann R; Raupach K; Bornemann J; Knuechel R; Pérez-Bouza A; Neuss S
    Biomaterials; 2010 Jan; 31(3):467-80. PubMed ID: 19815272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal mesenchymal stem cells in cancer therapy.
    Bitsika V; Vlahou A; Roubelakis MG
    Curr Stem Cell Res Ther; 2013 Mar; 8(2):133-43. PubMed ID: 23176305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell secretome and regenerative therapy after cancer.
    Zimmerlin L; Park TS; Zambidis ET; Donnenberg VS; Donnenberg AD
    Biochimie; 2013 Dec; 95(12):2235-45. PubMed ID: 23747841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Saijo Y; Tsuchida H; Ishioka S; Nishikawa A; Saito T; Fujimiya M
    Sci Rep; 2017 Aug; 7(1):8484. PubMed ID: 28814814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
    Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
    J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
    Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
    Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest.
    Ragni E; Viganò M; Parazzi V; Montemurro T; Montelatici E; Lavazza C; Budelli S; Vecchini A; Rebulla P; Giordano R; Lazzari L
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2456-66. PubMed ID: 23942228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources.
    Amati E; Perbellini O; Rotta G; Bernardi M; Chieregato K; Sella S; Rodeghiero F; Ruggeri M; Astori G
    Stem Cell Res Ther; 2018 Jan; 9(1):10. PubMed ID: 29338788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.
    Zhang X; Hirai M; Cantero S; Ciubotariu R; Dobrila L; Hirsh A; Igura K; Satoh H; Yokomi I; Nishimura T; Yamaguchi S; Yoshimura K; Rubinstein P; Takahashi TA
    J Cell Biochem; 2011 Apr; 112(4):1206-18. PubMed ID: 21312238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
    Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
    Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
    Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
    Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic biological characteristics of mesenchymal stem cells derived from bone marrow and human umbilical cord].
    Han ZX; Shi Q; Wang DK; Li D; Lyu M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1248-55. PubMed ID: 24156444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.